K

Karolinska Development AB
STO:KDEV

Watchlist Manager
Karolinska Development AB
STO:KDEV
Watchlist
Price: 1.21 SEK 0.17% Market Closed
Market Cap: 323.4m SEK
Have any thoughts about
Karolinska Development AB?
Write Note

Karolinska Development AB
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Karolinska Development AB
Revenue Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
IRLAB A
I
FLERIE

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
K
Karolinska Development AB
STO:KDEV
Revenue
kr1.9m
CAGR 3-Years
-4%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Calliditas Therapeutics AB
STO:CALTX
Revenue
kr1.6B
CAGR 3-Years
1 488%
CAGR 5-Years
63%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Revenue
kr1.6B
CAGR 3-Years
50%
CAGR 5-Years
94%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Revenue
kr2.5B
CAGR 3-Years
75%
CAGR 5-Years
85%
CAGR 10-Years
N/A
IRLAB Therapeutics AB
STO:IRLAB A
Revenue
kr5.7m
CAGR 3-Years
N/A
CAGR 5-Years
216%
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Revenue
kr100k
CAGR 3-Years
123%
CAGR 5-Years
0%
CAGR 10-Years
N/A

See Also

What is Karolinska Development AB's Revenue?
Revenue
1.9m SEK

Based on the financial report for Jun 30, 2024, Karolinska Development AB's Revenue amounts to 1.9m SEK.

What is Karolinska Development AB's Revenue growth rate?
Revenue CAGR 10Y
-9%

Over the last year, the Revenue growth was -12%. The average annual Revenue growth rates for Karolinska Development AB have been -4% over the past three years , -12% over the past five years , and -9% over the past ten years .

Back to Top